MyFinsight
Home
Blog
About
Cash and cash
equivalents
$42,990,371
(-48.53%↓ Y/Y)
Prepaid expenses and
other current assets
$2,828,491
(-17.57%↓ Y/Y)
Total current assets
$45,818,862
(-47.30%↓ Y/Y)
Operating lease
right-of-use lease asset
$241,224
(45.25%↑ Y/Y)
Property and equipment,
net
$74,068
(96.01%↑ Y/Y)
Total assets
$46,134,154
(-47.06%↓ Y/Y)
Total liabilities and
stockholders' equity
$46,134,154
(-47.06%↓ Y/Y)
Total stockholders'
equity
$38,172,051
(-53.76%↓ Y/Y)
Total liabilities
$7,962,103
(72.80%↑ Y/Y)
Accumulated deficit
-$154,142,307
(-42.48%↓ Y/Y)
Additional paid-in capital
$192,222,479
(0.83%↑ Y/Y)
Total current
liabilities
$7,884,579
(73.08%↑ Y/Y)
Operating lease liability
- non-current
$77,524
(48.13%↑ Y/Y)
Common stock, 0.001 par
value 300,000,000 and...
$91,879
(2.42%↑ Y/Y)
Accrued expenses and
other current...
$4,428,902
(116.62%↑ Y/Y)
Accounts payable
$3,288,209
(37.24%↑ Y/Y)
Operating lease liability
- current
$167,468
(45.64%↑ Y/Y)
Back
Back
Balance Sheet
Context Therapeutics Inc. (CNTX)
Context Therapeutics Inc. (CNTX)
source: myfinsight.com